These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 9699201)

  • 1. Inhibition of human immunodeficiency type 1 virus replication in monocytic U-937 cells by superinfection with Chlamydia trachomatis.
    Bianchi A; Ferchal F; Lejunter J; Scieux C
    New Microbiol; 1998 Jul; 21(3):221-32. PubMed ID: 9699201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.
    Ho JL; He S; Hu A; Geng J; Basile FG; Almeida MG; Saito AY; Laurence J; Johnson WD
    J Exp Med; 1995 Apr; 181(4):1493-505. PubMed ID: 7699332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1-infected women exhibit reduced interferon-gamma secretion after Chlamydia trachomatis stimulation of peripheral blood lymphocytes.
    Cohen CR; Nguti R; Bukusi EA; Lu H; Shen C; Luo M; Sinei S; Plummer F; Bwayo J; Brunham RC
    J Infect Dis; 2000 Dec; 182(6):1672-7. PubMed ID: 11069239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits.
    Tseng CK; Hughes MA; Hsu PL; Mahoney S; Duvic M; Sell S
    Am J Pathol; 1991 May; 138(5):1149-64. PubMed ID: 1850960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 does not significantly influence Chlamydia trachomatis serovar L2 replication in vitro.
    Broadbent A; Horner P; Wills G; Ling A; Carzaniga R; McClure M
    Microbes Infect; 2011 Jun; 13(6):575-84. PubMed ID: 21315827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 1 can either suppress or enhance human immunodeficiency virus type 1 replication in CD4-positive T lymphocytes.
    Calistri A; Parolin C; Palù G
    J Med Virol; 2003 May; 70(1):163-70. PubMed ID: 12629659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronmicroscopic study of human herpesvirus 6-infected human T cell lines superinfected with human immunodeficiency virus type 1.
    Takasaki T; Ohkawa N; Sano K; Morimatsu S; Nakano T; Nakai M; Yamaguchi J; Kurane I
    Acta Virol; 1997 Aug; 41(4):221-9. PubMed ID: 9391653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro study of a double infection by herpes simplex virus type 2 and Chlamydia trachomatis.
    Chiarini F; Mansi A; Pisani S; Seganti L; Brunori S; Gentile V; Di Silverio F
    New Microbiol; 1996 Jul; 19(3):263-6. PubMed ID: 8841043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of phorbol ester derivates on human immunodeficiency virus 1 replication in lymphocytic and monocytic human cells.
    Kalvatchev Z; Walder R; Garzaro D
    Acta Virol; 1997 Oct; 41(5):289-92. PubMed ID: 9607083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of inclusions following superinfection of HeLa cells by two serovars of Chlamydia trachomatis.
    Ridderhof JC; Barnes RC
    Infect Immun; 1989 Oct; 57(10):3189-93. PubMed ID: 2550371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis-infected host cells resist dsRNA-induced apoptosis.
    Böhme L; Albrecht M; Riede O; Rudel T
    Cell Microbiol; 2010 Sep; 12(9):1340-51. PubMed ID: 20482554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine model of ocular infection by a human biovar of Chlamydia trachomatis.
    Whittum-Hudson JA; O'Brien TP; Prendergast RA
    Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):1976-87. PubMed ID: 7657540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an MT4 cell line persistently producing infective HIV-1 particles.
    Gyuris A; Vajda G; Földes I
    Acta Microbiol Hung; 1992; 39(3-4):271-9. PubMed ID: 1364232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion.
    Tardieu M; Héry C; Peudenier S; Boespflug O; Montagnier L
    Ann Neurol; 1992 Jul; 32(1):11-7. PubMed ID: 1303631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells.
    Deka S; Vanover J; Dessus-Babus S; Whittimore J; Howett MK; Wyrick PB; Schoborg RV
    Cell Microbiol; 2006 Jan; 8(1):149-62. PubMed ID: 16367874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.